Testing effectiveness (Phase 2)WithdrawnNCT04363840
What this trial is testing
The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations
Who this might be right for
COVIDVitamin D DeficiencyCoagulopathy+1 more
Louisiana State University Health Sciences Center in New Orleans